---
$id: https://graph.org.ai/products/commodity/51271601
$type: Product
source: UNSPSC
code: "51271601"
title: "Cinchocaine or dibucaine"
class: "51271600"
classTitle: "Anaesthetic amides"
family: "51270000"
familyTitle: "Anaesthetic drugs and related adjuncts and analeptics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cinchocaine or dibucaine

**UNSPSC Code**: 51271601
**Class**: [Anaesthetic amides](Anaesthetic amides.mdx)
**Family**: [Anaesthetic drugs and related adjuncts and analeptics](../Anaesthetic drugs and related adjuncts and analeptics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anesthetic agent with the molecular formula C20H29N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L6JW2TJG99, chemically known as 4-quinolinecarboxamide, 2-butoxy-n-(2-(diethylamino)ethyl)- but generally known as cinchocaine, which bears US NIH Compound Identifier 3025. European Medicines Agency schedules Cinchocaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06287MIG. The term CINCHOCAINE is an International Non-Proprietary Name. World Health Organization schedules cinchocaine in its Anatomical Therapeutic Chemical (ATC) Classification. CINCHOCAINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Cinchocaine or dibucaine bears US NLM identifiers UMLS ID C0012050 and NCI Concept Code C28984. SMILES: CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC.

